600161 Stock Overview
Beijing Tiantan Biological Products Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Beijing Tiantan Biological Products Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.10 |
| 52 Week High | CN¥27.60 |
| 52 Week Low | CN¥20.17 |
| Beta | 0.37 |
| 11 Month Change | 0.96% |
| 3 Month Change | -7.18% |
| 1 Year Change | -13.25% |
| 33 Year Change | 7.40% |
| 5 Year Change | 44.27% |
| Change since IPO | 1,193.78% |
Recent News & Updates
Beijing Tiantan Biological Products Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Oct 29
Beijing Tiantan Biological Products (SHSE:600161) Ticks All The Boxes When It Comes To Earnings Growth
Oct 27Calculating The Fair Value Of Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161)
Oct 08Recent updates
Beijing Tiantan Biological Products Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Oct 29Beijing Tiantan Biological Products (SHSE:600161) Ticks All The Boxes When It Comes To Earnings Growth
Oct 27Calculating The Fair Value Of Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161)
Oct 08Beijing Tiantan Biological Products Co., Ltd.'s (SHSE:600161) Shares May Have Run Too Fast Too Soon
Sep 19Does Beijing Tiantan Biological Products (SHSE:600161) Deserve A Spot On Your Watchlist?
Jul 23Is Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 09Beijing Tiantan Biological Products Co., Ltd.'s (SHSE:600161) Price Is Out Of Tune With Earnings
May 22We Think Beijing Tiantan Biological Products (SHSE:600161) Can Stay On Top Of Its Debt
Mar 16Do Beijing Tiantan Biological Products' (SHSE:600161) Earnings Warrant Your Attention?
Mar 01Shareholder Returns
| 600161 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -2.3% | -6.3% | -4.1% |
| 1Y | -13.2% | -18.6% | 3.8% |
Return vs Industry: 600161 exceeded the CN Biotechs industry which returned -18.6% over the past year.
Return vs Market: 600161 underperformed the CN Market which returned 3.8% over the past year.
Price Volatility
| 600161 volatility | |
|---|---|
| 600161 Average Weekly Movement | 4.6% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 600161 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600161's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 4,858 | Dao Xing Fu | www.tiantanbio.com |
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include human albumin; intravenous human immunoglobulin; tetanus human immunoglobulin; rabies patient immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; and human prothrombin complex blood products.
Beijing Tiantan Biological Products Co., Ltd. Fundamentals Summary
| 600161 fundamental statistics | |
|---|---|
| Market cap | CN¥43.23b |
| Earnings (TTM) | CN¥1.27b |
| Revenue (TTM) | CN¥5.23b |
34.3x
P/E Ratio8.4x
P/S RatioIs 600161 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600161 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.23b |
| Cost of Revenue | CN¥2.35b |
| Gross Profit | CN¥2.89b |
| Other Expenses | CN¥1.61b |
| Earnings | CN¥1.27b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.64 |
| Gross Margin | 55.17% |
| Net Profit Margin | 24.36% |
| Debt/Equity Ratio | 0% |
How did 600161 perform over the long term?
See historical performance and comparison